IP Library Granted Patent US 9,850,202
Granted Patent B2
US 9,850,202 · App. 15/423,008 · Granted Dec 26, 2017

Ionizable cationic lipid for RNA delivery

Inventors: Joseph E. Payne (San Diego, CA); Padmanabh Chivukula (San Diego, CA)
Assignee: Arcturus Therapeutics, Inc.
C07C323/52C12N15/113C12N2310/14C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,850,202
App. No.
15/423,008
Granted
Dec 26, 2017
Kind
B2
Abstract

What is described is a compound wherein R 1 and R 2 are the same or different, each a linear or branched alkyl with 1-9 carbons, or an alkenyl or alkynyl with 2 to 11 carbons; L 1 and L 2 are the same or different, each a linear alkyl having 3 to 18 carbons; X 1 and X 3 are —CO—O—; X 3 is S or O; L 3 is a lower alkyl; R 3 is a lower alkyl; and R 4 and R 5 are the same or different, each a lower alkyl; or a pharmaceutically acceptable salt thereof.

Claims (62)

1. A compound of formula I

wherein

R 1 is a branched alkyl of 3, 4, 5, 6, 7, 8, or 9 carbons,

R 2 is a linear or branched alkyl of 1, 2, 3, 4, 5, 6, 7, 8, or 9 carbons, an alkenyl or alkynyl of 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 carbons, or cholesteryl,

L 1 and L 2 are the same or different, each a linear alkylene or alkenylene of 3 or 4 carbons,

X 1 is —CO—O— whereby -L 2 -CO—O—R 2 is formed,

X 2 is S or O,

X 3 is —CO—O— whereby -L 1 -CO—O—R 1 is formed,

L 3 is a bond, or a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons,

R 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons, and

R 4 and R 5 are the same or different, each hydrogen or a linear or branched alkyl of 1, 2, 3, 4, 5 or 6 carbons;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein L 1 and L 2 are the same.

3. The compound of claim 2 , wherein L 1 and L 2 are propylene.

4. The compound of claim 1 , wherein R 1 and R 2 are the same.

5. The compound of claim 1 , wherein L 3 is a bond.

6. A compound of formula 2

wherein

R 1 is branched alkyl of 3, 4, 5, 6, 7, 8, or 9 carbons,

R 2 is a linear or branched alkyl of 1, 2, 3, 4, 5, 6, 7, 8, or 9 carbons, an alkenyl or alkynyl of 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 carbons, or cholesteryl,

L 1 and L 2 are the same or different, each a linear alkylene or alkenylene of 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18 carbons,

X 1 is —CO—O— whereby -L 2 -CO—O—R 2 is formed,

X 2 is S or O,

X 3 is-CO—O— whereby -L 1 -CO—O—R 1 is formed,

L 3 is a bond, or a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons,

R 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons, and

R 4 and R 5 are the same or different, each a hydrogen, or a linear or branched alkyl of 1, 2, 3, 4, 5 or 6 carbons;

or a pharmaceutically acceptable salt thereof.

7. The compound of claim 6 , wherein L 3 is methylene.

8. The compound of claim 6 , wherein R 4 and R 5 are independently methyl or ethyl.

9. The compound of claim 6 , wherein R 3 is ethylene or propylene.

10. The compound of claim 6 , wherein X 2 is S.

11. The compound of claim 6 , wherein R 1 and R 2 are the same.

12. The compound of claim 11 , wherein R 2 is an alkyl of 1, 2, or 3 carbons.

13. The compound of claim 11 , wherein R 2 is an alkenyl of 9, 10, or 11 carbons.

14. The compound of claim 6 , wherein L 1 and L 2 are the same.

15. The compound of claim 14 , wherein L 1 and L 2 are an alkylene of 3, 4, 5, 6, or 7 carbons.

16. The compound of claim 14 , wherein L 1 and L 2 are an alkenylene of 13, 14, or 15 carbons.

17. The compound of claim 6 , wherein X 2 is 0.

18. The compound of claim 6 , wherein L 3 is a bond.

19. A compound of formula I

wherein

R 1 and R 2 are the same or different, each a linear or branched alkyl of 1, 2, 3, 4, 5, 6, 7, 8, or 9 carbons, an alkenyl or alkynyl of 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 carbons, or cholesteryl,

L 1 and L 2 are propylene,

X 1 is —CO—O— whereby -L 2 -CO—O—R 2 is formed,

X 2 is S or O,

X 3 is −CO—O— whereby -L 1 -CO—O—R 1 is formed,

L 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons,

R 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons, and

R 4 and R 5 are the same or different, each hydrogen or a linear or branched alkyl of 1, 2, 3, 4, 5 or 6 carbons;

or a pharmaceutically acceptable salt thereof.

20. A compound of formula 2

wherein

R 1 and R 2 are the same, each an alkyl of 1, 2, or 3 carbons,

L 1 and L 2 are the same or different, each a linear alkylene or alkenylene of 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18 carbons,

X 1 is —CO—O— whereby -L 2 -CO—O—R 2 is formed,

X 2 is S or O,

X 3 is —CO—O— whereby -L 1 -CO—O—R 1 is formed,

L 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons,

R 3 is a linear or branched alkylene of 1, 2, 3, 4, 5 or 6 carbons, and

R 4 and R 5 are the same or different, each a hydrogen, or a linear or branched alkyl of 1, 2, 3, 4, 5 or 6 carbons;

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2017
From: PAYNE, JOSEPH E.; CHIVUKULA, PADMANABH
To: ARCTURUS THERAPEUTICS, INC.
Reel/Frame 044111/0048 →
Continuity (3)
Division 14546105 · Nov 18, 2014
Provisional Application 61905724 · Nov 18, 2013
Related Publication 20170144967A1 · May 25, 2017